SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
SocialPicks Community
Investars YOU: New Site for Index Tracking and Investing
BBH
New Website for Healthcare Investors and Traders
BBH
|
|
|
-45.74%
in
136 days
(closed on 06/26/09)
<> A new website for healthcare investors and traders should be ready to launch by the end of February, which is designed to provide users with more features beyond my current blog format.
The site will feature its own blog, discussion forum, news feeds, videos, stock commentaries (including multiple contributors), and other unique content – including my FDA and Clinical Trial Calendars plus a database that includes hundreds of foreign and U.S.-listed stocks in the healthcare sector which are organized into unique indexes, including:
1....
|
One Year Analysis of Healthcare ETFs
BBH
|
|
|
+4.04%
in
19 days
(closed on 02/10/09)
<> The table at my website link below includes a summary and statistics for the 25 healthcare exchange-traded funds (ETFs) which are currently on the market. The group posted a 23.5% loss over the past year on an equal-weight basis with an average of about $400M in net assets. However, the top eight ETFs by net assets account for 88.5% of all net assets for the entire group of 25, including Healthcare Sector SPDR (XLV), Pharma HOLDRs (PPH), iShares Nasdaq Biotech (IBB), Biotech HOLDRs (BBH), iShares Dow Jones U.S. Healthcare (IYH), iShares S&P Global Healthcare (IXJ), Vanguard Healthcare (VHT...
|
Beyond Active ETFs: Build Your Own
BBH
|
|
|
-3.63%
in
4 days
(closed on 01/22/09)
<> Index Universe reported last week that Grail Partners has requested SEC approval to launch two new exchange-traded funds (ETFs) which are actively managed and do not track an underlying index. The Grail American Beacon Large Cap Value ETF and the Grail American Beacon International Equity ETF would not have any restrictions on trading, but Grail expects to provide more details on target turnover rates for the funds once the managers and investment strategy is in place.
As an alternative investing strategy, why not create your ow...
|
ETF Innovators: 24 New Product Ideas
BBH
|
|
|
+0.00%
in
23 hours
(closed on 01/18/09)
ETF Innovators: 24 New Product Ideas Below are 24 new exchange-traded product (ETP) ideas, which are organized by the following sectors and themes: transports (six), healthcare (11), Non-Healthcare (five), and commodities (two). The 20 stock-based ETF ideas below are structured as semi-active indexes with monthly rebalancing to choose the top rated stocks as active components on an equal-weight basis. <> Most of the ideas represent first-to-market ideas and several such as Air and...
|
From the Blogosphere
The best ETFs for betting on biotech
BBH
-0.56%
in
110 days
Filed under: Newsletters, Stocks to Buy "I'm always looking for market leadership; right now, biotechnology stocks are moving up faster than most anything else," says Ron Rowland. In Money & Markets, he eyes biotech ETFs. "Biotechnology is a fascinating sector, one that's made (and lost) a lot of money for millions of investors in recent decades. That's why, in my opinion, you should become familiar with this industry. "Broadly speaking, it's the application of technology to biological materials - plants, animals and people. <>"Nowadays a lot of biotechnology involves manipulating genetic materia...
|
ETFs for betting on biotech
|
|
|
 "I'm always looking for market leadership; right now, biotechnology stocks are moving up faster than most anything else," says Ron Rowland. In Money & Markets, he eyes biotech ETFs.
"Biotechnology is a fascinating sector, one that's made (and lost) a lot of money for millions of investors in recent decades. That's why, in my opinion, you should become familiar with this industry. "Broadly speaking, it's the application of technology to biological materials — plants, animals and people. <>"Nowadays a lot of biotechnology involves manipulating genetic material: The DNA that forms the basis for l...
|
Most Overbought and Oversold ETFs
Stem Cell Index Down 7% in Past Week
|
|
|
The accompanying table (click to enlarge) includes 26 companies in the ETF Innovators Emerging Stem Cell Index, which lost 7% of its market value in the past week (at 1,148 today) and posted a 15.2% loss over the past year on an equal-weight basis.
Results for benchmark indexes and ETFs include gains of 1.5% for the Cosmetic and Restorative Medicine Index and losses of 1.2% for SPDR S&P Biotech (XBI), 18.7% for Healthcare Sector SPDR (XLV), 7.2% for iShares Nasdaq Biotech (IBB), and 17.7% for PowerShares Biotech & Genome (PBE).
The next catalyst expected for stem cell and regenerative medicin...
|
New Website Coming Soon!
|
|
|
A new website for healthcare investors and traders should be ready to launch by the end of February, which is designed to provide users with more features beyond my current blog format.
The site will feature its own blog, discussion forum, news feeds, videos, stock commentaries (including multiple contributors), and other unique content – including my FDA and Clinical Trial Calendars plus a database that includes hundreds of foreign and U.S.-listed stocks in the healthcare sector which are organized into unique indexes, including:
1.) Emerging Stem Cell Research – StemCells (STEM)< />< />< />< />< />< />< />< />< />< />< />< /><><>< />< /><>< />< /><>< />< /><>< />< />< />< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><><><>< /><><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< />< />...
|
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
Visit streetinsider.com
Be the first to start a discussion and earn 2 points.
More Resources
|
About Biotech HOLDRs Trust Biotech HOLDRs Trust
- Answers.com
